Zobrazeno 1 - 10
of 143
pro vyhledávání: '"F. Ganz"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
W. Maksymowych, X. Baraliakos, A. Deodhar, D. Poddubnyy, F. Ganz, T. Gao, J. Stigler, A. Shmagel, P. Wung, M. Breban, F. Van Den Bosch
Publikováno v:
Revue du Rhumatisme. 89:A183-A184
Autor:
X. Baraliakos, F. Ganz, H. Kameda, J.A. Walsh, M. Jain, K. D'silva, P. Wung, X. Bu, J. Stigler, P. Goupille, D. Van Der Heijde
Publikováno v:
Revue du Rhumatisme. 89:A184-A185
Autor:
W, Sepúlveda-Loyola, I, Rodríguez-Sánchez, P, Pérez-Rodríguez, F, Ganz, R, Torralba, D V, Oliveira, L, Rodríguez-Mañas
Publikováno v:
The Journal of Nutrition, Health & Aging
Objectives To review the impact of social isolation during COVID-19 pandemic on mental and physical health of older people and the recommendations for patients, caregivers and health professionals. Design Narrative review. Setting Non-institutionaliz
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
X. Baraliakos, R. Ranza, A. Ostor, F. Ciccia, L. Coates, S. Rednic, J. A. Walsh, T. Gao, A. Lertratanakul, I. H. Song, F. Ganz, K. Douglas, A. Deodhar
Publikováno v:
Annals of the Rheumatic Diseases. 81:768-768
BackgroundPatients with PsA and axial involvement have higher disease activity and greater reductions in quality of life;1 however, there are no accepted criteria for identifying axial involvement in PsA.ObjectivesThe objective of this post-hoc analy
Autor:
A. Lertratanakul, I. H. Song, Laura C. Coates, Roberto Ranza, Xenofon Baraliakos, S. Rednic, A. Deodhar, A. Ostor, T. Gao, F. Ganz, Francesco Ciccia
Publikováno v:
Annals of the Rheumatic Diseases. 80:338-339
Background:Axial, peripheral, and other disease manifestations often overlap between psoriatic arthritis (PsA) and ankylosing spondylitis (AS). Upadacitinib (UPA) is an oral Janus kinase inhibitor under evaluation for the treatment of PsA and AS.Obje
Autor:
A. Biljan, M. Pinheiro, T. Gao, Marina Magrey, Martin Rudwaleit, F. Ganz, Sofia Ramiro, Nigil Haroon, I. H. Song
Publikováno v:
Annals of the Rheumatic Diseases. 80:723-724
Background:Upadacitinib (UPA) is an oral Janus kinase inhibitor that has demonstrated efficacy and safety among patients with ankylosing spondylitis (AS) in the phase 2/3 SELECT-AXIS 1 study.1 If identified, early predictors of treatment response may
Publikováno v:
Annals of the Rheumatic Diseases. 80:143-144
Background:Patients (pts) with psoriatic arthritis (PsA) and axial involvment exhibit greater disease activity and quality of life impairments compared with those without axial involvment.Objectives:To characterize PsA pts with and without axial invo
Autor:
F. Ganz, Ediz Dalkilic, S.A.L. Lima, R. Horváth, Wolf-Henning Boehncke, M. Okada, Ennio Lubrano, M. Hojnik
Publikováno v:
Journal of the European Academy of Dermatology and Venereology, Vol. 34, No 9 (2020) pp. 2035-2043
Background Psoriatic arthritis (PsA) is a chronic and debilitating disease that can be managed by different clinical specialists. Objectives The objective of theLOOPstudy was to evaluate the impact of clinical specialty setting on the time to diagnos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::defd6b59ba77264778880491aacfba81
http://hdl.handle.net/11452/30591
http://hdl.handle.net/11452/30591